Melt-in-mouth pellets of fexofenadine hydrochloride using crospovidone as an extrusion-spheronisation aid

AAPS PharmSciTech

Volumn 11, Issue 2, 2010, Pages 917-923

  Jain, Satishkumar P ^a   Mehta, Dharmini C ^a   Shah, Sejal P ^a   Singh, Pirthi Pal ^a   Amin, Purnima D ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Crospovidone (Polyplasdone XL 10); Fexofenadine hydrochloride; Ion exchange resin; Melt in mouth pellets; Microcrystalline cellulose; Taste masking

Indexed keywords

CROSPOVIDONE; FEXOFENADINE; ION EXCHANGE RESIN; ANTIALLERGIC AGENT; EXCIPIENT; MICROCAPSULE; POVIDONE; TERFENADINE;

ARTICLE; CONTROLLED STUDY; DRUG MANUFACTURE; DRUG PELLET; PELLET EXTRUSION; PRIORITY JOURNAL; SPHERONIZATION; ANALOGS AND DERIVATIVES; CHEMISTRY; DRUG FORMULATION; DRUG STABILITY; MICROCAPSULE; MOUTH; ORAL DRUG ADMINISTRATION; PROCEDURES; SOLUBILITY; SYNTHESIS;

ADMINISTRATION, ORAL; ANTI-ALLERGIC AGENTS; CAPSULES; DRUG COMPOUNDING; DRUG STABILITY; EXCIPIENTS; MOUTH; POVIDONE; SOLUBILITY; TERFENADINE;

EID: 77954815887     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9443-7     Document Type: Article

References (44)

1. Law M, Deasy P. Use of hydrophilic polymers with microcrystalline cellulose to improve extrusion - spheronization. Euro J Pharm Biopharm. 1998;45:57-65.
2. Lustig-Gustafsson C, Kaur JH, Podczeck F, Newton JM. The influence of water content and drug solubility on the formulation of pellets by extrusion and spheronization. Eur J Pharm Sci. 1999;8:147-52.
3. Kleinebudde P. Shrinking and swelling properties of pellets containing microcrystalline cellulose and low substituted hydroxypropylcellulose: II. Swelling properties. Int J Pharm. 1994;109:221-7. (Pubitemid 24240117)
4. Schroder M, Kleinebudde P. Development of disintegrating pellets obtained from extrusion/spheronization. Pharm Sci. 1995;1:415-8.
5. Lindner H, Kleinebudde P. Use of powdered cellulose for the production of pellets by extrusion/spheronization. J Pharm Pharmacol. 1994;46:2-7.
6. Millili GP, Schwartz JB. The strength of microcrystalline cellulose pellets-the effect of granulating with water ethanol mixtures. Drug Dev Ind Pharm. 1990;16:1411-26.
7. Okada S, Nakahara H, Isaka H. Adsorption of drugs on microcrystalline cellulose suspended in aqueous solutions. Chem Pharm Bull. 1987;35:761-8.
8. Basit AW, Newton JM, Lecey LF. Formulation of ranitidine pellets by extrusion/spheronization with a little and with no microcrystalline cellulose. Pharm Dev Technol. 1999;4:499-505.
9. Liew CV, Josephine LG, Soh LP, Heng PW. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose. Pharm Res. 2005;22:1387-98.
10. Bornhoft M, Thommes M, Kleinebudde P. Preliminary assessment of carrageenan as excipient for extrusion/spheronization. Eur J Pharm Biopharm. 2005;59:127-31.
11. Thommes M, Blaschek W, Kleinebudde P. Effect of drying on extruded pellets based on κ - carrageenan. Eur J Pharm Sci. 2007;31:112-8.
12. Thommes M, Kleinebudde P. Use of κ - carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronization. I. Influence of type and fraction of filler. Eur J Pharm Biopharm. 2006;63:59-67.
13. Steckel H, Mindermann-Nogly F. Production of chitosan pellets by extrusion/spheronization. Eur J Pharm Biopharm. 2004;57:107-14.
14. Chatchawalsaisin J, Podczeck F, Newton JM. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronization. Int J Pharm. 2004;275:41-60.
15. Santos H, Veiga F, Pina M, Podczeck F, Sausa J. Physical properties of chitosan pellets produced by extrusion - spheronization: influence of formulation variables. Int J Pharm. 2002;246:153-69.
16. Agrawal AM, Manek RV, Kolling WM, Neau SH. Water distribution studies within microcrystalline cellulose and chitosan using differential scanning calorimetry and dynamic vapour sorption analysis. J Pharm Sci. 2004;93(7):1766-79.
17. Tho I, Sande SA, Kleinebudde P. Pectinic acid, a novel excipient for production of pellets by extrusion/spheronization: preliminary studies. Eur J Pharm Biopharm. 2002;54:95-9.
18. Tho I, Sande SA, Kleinebudde P. Disintegrating pellets from a water-insoluble pectin derivative produced by extrusion/spheronization. Eur J Pharm Biopharm. 2003;56:371-80.
19. Tho T, Kleinebudde P, Sande SA. Extrusion/spheronization of pectin-based formulations. I. Screening of important factors. AAPS PharmSciTech. 2002;2(4):26.
20. ®- based multi-unit erosion matrix. Int J Pharm. 2001;213:7-12.
21. Chatlapalli R, Rohera BD. Physical characterization of HPMC and HEC and investigation of their use as pelletisation aids. Int J Pharm. 1998;161:179-93.
22. Howard MA, Neau SH, Sack MJ. PEO and MPEG in high drug load extruded and spheronised beads that are devoid of MCC. Int J Pharm. 2006;307:66-76.
23. Almeida S, Prieto J, Mendez B, Espinar O. Starch - dextrin mixtures as base excipients for extrusion-spheronization pellets. Eur J Pharm Biopharm. 2005;59:511-21.
24. Dukić A, Mens R, Adriaensens P, Foreman C, Gelan J, Remon JP, et al. Development of starch based pellets via extrusion/spheronization. Eur J Pharm Biopharm. 2007;66:83-94.
25. Chui CW, Henley M, Paul A. Inventors Process for making amylase resistant starch from high amylose starch. U. S. Patent 5, 281, 276, 1994.
26. International Specialty Products, Technical profile: Crospovidone.
27. Kornblum SS, Stoopak SB. A new tablet disintegrating agent: crosslinked Polyvinylpyrrolidone. J Pharm Sci. 1973;62:43-9.
28. Rudnic EM, Lausier JM, Chilamkurti RN, Rhodes CT. Studies of the utility of cross linked polyvinylpolypyrrolidine as a tablet disintegrant. Drug Dev Ind Pharm. 1980;6:291-309.
29. Gordon MS, Chowhan ZT. Effect of tablet solubility and hygroscopicity on disintegrant efficiency in direct compression tablets in terms of dissolution. J Pharm Sci. 1987;76:907-9.
30. Gordon MS, Rudraraju VS, Dani K, Chowhan ZT. Effect of the mode of super disintegrant incorporation on dissolution in wet granulated tablets. J Pharm Sci. 1993;82:220-6.
31. Schiermeier S, Schmidt PC. Fast dispersible ibuprofen tablets. Eur J Pharm Sci. 2002;15(3):295-305.
32. FAO/WHO. Evaluation of certain food additives and contaminants. Twenty-seventh report of the joint FAO/WHO expert committee on food additives. World Health Organ Tech Rep Ser (1983) No. 696.
33. Fielden KE, Newton JM, O'Brien P, Rowe RC. Thermal studies of the interaction of water and microcrystalline cellulose. J Pharm Pharmacol. 1988;40:674-8.
34. Markham A, Wagstaff AJ. Fexofenadine. Drugs. 1998;55(2):269-74.
35. Simpson A, Jarvis B. Fexofenadine: a review of its use in management of seasonal allergic rhinitis and chronic idiopathic urticaria. Drugs. 2000;59(2):301-21.
36. O'Neil MJ, Smith A, Heckelman PE, Budavari S, editors; The Merck Index: an encyclopedia of chemicals, drugs and biologicals, 13th Edn. Merck, New Jersey; 2001, 4097pp.
37. Buhler V. Polyvinylpyrrolidone excipients for pharmaceuticals. New York: Springer; 2005. 150pp.
38. Tokuyama E, Shibasaki T, Kawabe H, Mukai J, Okada S, Uchida T. Bitterness suppression of BCAA solutions by L-ornithine. Chem Pharm Bull. 2006;54:1288-92.
39. Erkoboni DF. Extrusion/spheronization. In: Ghebre-Sellasie I, Martin C, editors. Pharmaceutical Extrusion Technology. New York: Marcel Dekker; 2003. p. 277-322.
40. Malinowski HJ, Smith WE. Use of factorial design to evaluate granulations prepared by spheronization. J Pharm Sci. 1975;64:1688-92.
41. O'Connor RE, Schwartz JB. Extrusion and spheronization technology. In: Ghebre-Sellasie I, editor. Pharmaceutical Pelletization Technology. New York: Marcel Dekker; 1989. p. 187-216.
42. Zhang G, Schwartz JB, Schnaare RL, Wigent RJ, Sugita ET. Bead coating: II. effect of spheronization technique on dissolution from coated spheres. Drug Dev Ind Pharm. 1991;17:817-30.
43. Albertini B, Cavallari C, Passerini N, Voinovich D, Gonzalez-Rodriguez ML, Magarotto L, et al. Characterization and tastemasking evaluation of acetaminophen granules: comparison between different preparation methods in a high shear mixer. Eur J Pharm Sci. 2004;21:295-303.
44. Staniforth JN. Powder flow. In: Aulton ME, editor. Pharmaceutics: the science of dosage form design. London: Churchill Livingstone; 1988. p. 600-15.